127 related articles for article (PubMed ID: 7912212)
1. [Taxol--a new cytostatic drug for therapy of ovarian and breast cancer].
Meden H; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):187-93. PubMed ID: 7912212
[TBL] [Abstract][Full Text] [Related]
2. Taxol: an important new drug in the management of epithelial ovarian cancer.
Markman M
Yale J Biol Med; 1991; 64(6):583-90. PubMed ID: 1687343
[TBL] [Abstract][Full Text] [Related]
3. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
[TBL] [Abstract][Full Text] [Related]
4. Salvage weekly paclitaxel in recurrent ovarian cancer.
Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
[TBL] [Abstract][Full Text] [Related]
5. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
Holmes FA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702
[TBL] [Abstract][Full Text] [Related]
6. Taxol: initial Israeli experience with a novel anticancer agent.
Sulkes A; Beller U; Peretz T; Shacter J; Hornreich G; McDaniel C; Winograd B
Isr J Med Sci; 1994 Jan; 30(1):70-8. PubMed ID: 7908013
[TBL] [Abstract][Full Text] [Related]
7. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
Mayerhofer K; Kucera E; Zeisler H; Speiser P; Reinthaller A; Sevelda P
Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
9. Taxol in epithelial ovarian cancer.
Caldas C; McGuire WP
J Natl Cancer Inst Monogr; 1993; (15):155-9. PubMed ID: 7517152
[TBL] [Abstract][Full Text] [Related]
10. Clinical development of Taxol.
Arbuck SG; Christian MC; Fisherman JS; Cazenave LA; Sarosy G; Suffness M; Adams J; Canetta R; Cole KE; Friedman MA
J Natl Cancer Inst Monogr; 1993; (15):11-24. PubMed ID: 7912517
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer.
Gregory RE; DeLisa AF
Clin Pharm; 1993 Jun; 12(6):401-15. PubMed ID: 7691462
[TBL] [Abstract][Full Text] [Related]
13. [Evidenced-based medicine and future direction of Taxol].
Hatae M; Nakamura T; Ohnishi Y
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1279-87. PubMed ID: 10945027
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel (Taxol) in breast cancer.
Arbuck SG; Dorr A; Friedman MA
Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel (Taxol) therapy in ovarian carcinoma.
Caldas C; McGuire WP
Semin Oncol; 1993 Aug; 20(4 Suppl 3):50-5. PubMed ID: 7688146
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
18. Biweekly paclitaxel (Taxol) and cisplatin in breast and ovarian cancer.
Gelmon KA
Semin Oncol; 1994 Oct; 21(5 Suppl 8):24-8. PubMed ID: 7939758
[TBL] [Abstract][Full Text] [Related]
19. [Favorable remission rates of metastatic breast cancer with taxol therapy].
Med Klin Suppl; 1993 Nov; 2():10-3. PubMed ID: 7904714
[No Abstract] [Full Text] [Related]
20. Taxol: a new drug with significant activity as a salvage therapy in advanced epithelial ovarian carcinoma.
McGuire WP
Gynecol Oncol; 1993 Oct; 51(1):78-85. PubMed ID: 7902314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
